1.

2.

3.

4.

 ?
,

"psoros"
", "

a,

,

94

Scaling

79

Itching

71

Skin redness

31

Tightness of skin

29

Bleeding

21

Burning sensation

19

Fatigue

Other
0

20

40

60

80

100

Percentage of respondents (n = 17,425)

Adapted from Krueger G et al. Arch Dermatol 2001; 137: 2804.

(80%)
(78%)
(74%)
(57%)
(10-55%)

/(12%)




("
")

/

Psoriasis mistaken
as contagious

Psoriasis mistaken for

other disease

Trouble receiving
equal treatment in
service establishments
(e.g. hair salons,
public pools)

Adapted from Krueger G et al. Arch Dermatol 2001; 137: 2804.




(" ")

(" ")

Adapted from Krueger G et al. Arch Dermatol 2001; 137: 2804.

11

~ 0.32.5%

~ 60 per 100,000

12


: ~ 2337

:

1. ( I ,
, )

2. 40- ( II ,
, )

13

-
- -


,
10 : HLA-Cw6, IL23 p19, IL-12/IL-23 p40, IL-23R

14

( , )
(Koebner )

( )
()

15


T-


-

1. Lee M et al. Australas J Dermatol 2006; 47: 1519.

16


:
<5%
(65% )
:
5-10%
(25% )
:
10%
(10% )


( )
"", "" "" :

,

,

19





, ,

20

21

22

Psoriasis punctata -

Psoriasis guttata -

Psoriasis nummularis -

Psoriasis in placibus (en plakues) -

Psoriasis annularis
Psoriasis geographica


85%

, ,

23

24

25

26

27



- ~ 1 cm

<30

28

29

, ,

30


:
1.

2.

31

32

33






:
,

34


:



: o

35

36

37


5-20%


1.

2.

3.

4.
5. ,

38

39

40

Tinea corporis

Tinea coporis

Psoriasis

41

Discoid eczema

Psoriasis

42

Dermatitis
Psoriasis

43

Pityriasis rosea

8-12

< Psoriasis

^ Pityriasis rosea


Tinea manum

Tinea corporis

Psoriasis

44


eczema

:
,

,

Eczema

Psoriasis

45

46

47

48

49

50


70%

51

,
:

52

53

Dithranol
Tazarotene
alcipotriol .

54

-,

55

56

57



> 10%
-

2-3 /

58

59

5%
(, ,
, )

61

62

63

Etanercept
Adalimumab
Infliximab
(IL-12 and IL-32)
Ustekinumab

64